27 results
S-4/A
EX-10.9
CELU
Celularity Inc - Ordinary Shares
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
public accountant, an appraiser, investment banker or other expert selected with reasonable care by the Enterprise or its board of directors or any
S-4/A
EX-10.26
CELU
Celularity Inc - Ordinary Shares
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
from and against any and all third party claims, losses, liabilities, damages, costs, and expenses (including attorneys’ fees, expert witness fees
DEF 14A
CELU
Celularity Inc - Ordinary Shares
4 Dec 20
Definitive proxy
5:23pm
is financially literate, and our board of directors has determined that Mr. Mazur qualifies as an “audit committee financial expert” as defined in applicable
S-4/A
EX-10.27
r1jpq
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
10-K
e5eygknixfhaw65zcgj
24 Mar 20
Annual report
12:00am
425
EX-2.1
rs1uv7xd6hcuojto
8 Jan 21
Business combination disclosure
7:02am
8-K
EX-2.1
v2zr orq9x03wm62wjn2
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
424B4
luxdbd4 knnc
21 May 19
Prospectus supplement with pricing info
2:26pm
DRS/A
umfps36
28 Mar 19
Draft registration statement (amended)
12:00am
S-1
p7qb2wch
26 Apr 19
IPO registration
4:23pm
DRS
b54q5lg nrbgw
5 Nov 18
Draft registration statement
12:00am
424B3
ik3evskiuzj9xb
3 May 22
Prospectus supplement
4:06pm